Australia markets close in 2 hours 2 minutes

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
60.72+0.02 (+0.03%)
At close: 04:00PM EST
61.50 +0.78 (+1.28%)
After hours: 07:48PM EST
Full screen
Trade prices are not sourced from all markets
Previous close60.70
Bid60.09 x 900
Ask64.00 x 1200
Day's range53.97 - 60.95
52-week range53.97 - 189.89
Avg. volume511,196
Market cap1.811B
Beta (5Y monthly)1.34
PE ratio (TTM)3.19
EPS (TTM)19.06
Earnings date02 Mar 2022 - 07 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est141.00
  • Motley Fool

    Why Shares of Fulgent Genetics Nearly Doubled in 2021

    Shares of diagnostic testing company Fulgent Genetics (NASDAQ: FLGT) were up 93% last year, according to S&P Global Market Intelligence. The unpredictability of COVID took shareholders on a journey through several peaks and valleys on the way to that gain. The roller coaster has continued into 2022 with the stock down nearly 20% year to date already.

  • Zacks

    4 Profitable Stocks to Boost Returns Using Net Income Ratio

    FLGT, LGO, CTRN, and TGH have been selected as the top picks with a high net income ratio.

  • Motley Fool

    3 COVID Stocks That Could Double in 2022

    Read more to see why three contributors think COVID stocks Fulgent Genetics (NASDAQ: FLGT), NRx Pharmaceuticals (NASDAQ: NRXP), and Adaptive Biotechnologies (NASDAQ: ADPT) could double your money this year. Will this stock turn on? Patrick Bafuma (Fulgent Genetics): Entering the last wave of 2021, you may have heard that there was a run on COVID tests.